<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37714919</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Risk of long COVID main symptoms after SARS-CoV-2 infection: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>15332</StartPage><MedlinePgn>15332</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">15332</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-42321-9</ELocationID><Abstract><AbstractText>This review aimed to summarise the relative risk (RR) of the main symptoms of long COVID in people infected with SARS-CoV-2 compared to uninfected controls, as well as the difference in health-related quality of life (HRQoL) after infection. MEDLINE, EMBASE, PubMed, NLM-LitCovid, WHO-COVID-19, arXiv and Europe-PMC were searched up to 23rd March 2022. Studies reporting risk (four or more weeks after infection) of fatigue, shortness of breath, and cognitive dysfunction, as well as comparative HRQoL outcomes, were included. Pairwise random-effects meta-analyses were performed to pool risks of individual symptoms. Thirty-three studies were identified; twenty studies reporting symptom risks were included in the meta-analyses. Overall, infection with SARS-CoV-2 carried significantly higher risk of fatigue (RR 1.72, 95% confidence intervals [CIs] 1.41, 2.10), shortness of breath (RR 2.60, 95% CIs 1.96, 3.44), memory difficulties (RR 2.53, 95% CIs 1.30, 4.93), and concentration difficulties (RR 2.14, 95% CIs 1.25, 3.67). Quality of life findings were varied and comparisons between studies were challenging due to different HRQoL instruments used and study heterogeneity, although studies indicated that severe hospitalised COVID is associated with a significantly poorer HRQoL after infection. These risks are likely to constantly change as vaccines, reinfections, and new variants alter global immunity.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marjenberg</LastName><ForeName>Zoe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Maverex Ltd, Suite A, 168 Brinkburn Street, The Old Public Library, Newcastle Upon Tyne, NE6 2AR, UK. zoemarjenberg@maverex.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leng</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins Center on Aging and Immune Remodelling, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tascini</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Infectious Diseases Clinic, Department of Medicine (DAME), Udine University, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Megha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Maverex Ltd, Suite A, 168 Brinkburn Street, The Old Public Library, Newcastle Upon Tyne, NE6 2AR, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Misso</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Maverex Ltd, Suite A, 168 Brinkburn Street, The Old Public Library, Newcastle Upon Tyne, NE6 2AR, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Guerche Seblain</LastName><ForeName>Clotilde</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sanofi, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaikh</LastName><ForeName>Nabila</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sanofi, Reading, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Review funded by Sanofi. Sean Leng and Carlo Tascini have no conflicts to declare. Nabila Shaikh and Clotilde El Guerche Seblain are employees of Sanofi and hold stock and/or stock options in the company. Zoe Marjenberg, Megha Garg and Kate Misso are employees of Maverex Ltd and received funding for their role in conducting the SLR.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>16</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37714919</ArticleId><ArticleId IdType="pmc">PMC10504382</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-42321-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-42321-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>NICE. Overview|COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance|NICE. 1&#x2013;111 https://www.nice.org.uk/guidance/ng188 (2021).</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. 27 file:///C:/Users/pbradley/Downloads/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf (2021).</Citation></Reference><Reference><Citation>Michelen M, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6:e005427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, et al. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. J. Infect. Dis. 2022 doi: 10.1093/INFDIS/JIAC136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIAC136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 2022;13(1):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S, et al. Fatigue symptoms associated with COVID-19 in convalescent or recovered COVID-19 patients; a systematic review and meta-analysis. Ann. Behav. Med. 2022;56:219&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8574547</ArticleId><ArticleId IdType="pubmed">34665858</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Intern. Med. 2021;92:55&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:5427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization, W. H. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021).</Citation></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin-Chowdhury Z, et al. Characterising long COVID more than 6 months after acute infection in adults; prospective longitudinal cohort study, England. medRxiv. 2021 doi: 10.1101/2021.03.18.21253633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.18.21253633</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children&#x2014;A nationwide cohort study. Eur. J. Pediatr. 2022;181:1597&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur. J. Epidemiol. 2022;37:539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro VM, Rosand J, Giacino JT, McCoy TH, Perlis RH. Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems. Mol. Psychiatry. 2022 doi: 10.1038/s41380-022-01646-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01646-z</ArticleId><ArticleId IdType="pmc">PMC9199464</ArticleId><ArticleId IdType="pubmed">35705635</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevinsky JR, et al. Late conditions diagnosed 1&#x2013;4 months following an initial coronavirus disease 2019 (COVID-19) encounter: A matched-cohort study using inpatient and outpatient administrative data-United States, 1 March-30 June 2020. Clin. Infect. Dis. 2021;73:S5&#x2013;S16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135331</ArticleId><ArticleId IdType="pubmed">33909072</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges F, et al. Post-COVID-19 syndrome in outpatients: A cohort study. J. Gen. Intern. Med. 2022;37:1943&#x2013;1952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8939498</ArticleId><ArticleId IdType="pubmed">35319081</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S, et al. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolesc. Health. 2022;6:240&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, et al. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: A cross-sectional study of patients tested between March 2020 and November 2021. medRxiv. 2022 doi: 10.1101/2022.01.05.22268800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.05.22268800</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among french adults during the COVID-19 pandemic. JAMA Intern. Med. 2022;182:19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Noviello D, et al. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study. Neurogastroenterol. Motil. 2022;34:e14187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209890</ArticleId><ArticleId IdType="pubmed">34060710</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Izquierdo M, et al. Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes&#x2014;A multicentre cohort study. BMC Med. 2022;20:92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863509</ArticleId><ArticleId IdType="pubmed">35193574</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M, et al. Post COVID-19 in children, adolescents, and adults: Results of a matched cohort study including more than 150,000 individuals with COVID-19. medRxiv. 2021 doi: 10.1101/2021.10.21.21265133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.21.21265133</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Roge I, et al. Comparison of persistent symptoms after COVID-19 and other non-SARS-CoV-2 infections in children. Front. Pediatr. 2021;9:752385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8586002</ArticleId><ArticleId IdType="pubmed">34778143</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rensen AIV, et al. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark. Nat. Commun. 2022;13(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9302226</ArticleId><ArticleId IdType="pubmed">35864108</ArticleId></ArticleIdList></Reference><Reference><Citation>Spotnitz, M., Hripcsak, G., Ryan, P., medRxiv, K. N.- &amp; 2021, undefined. Characterizing post-acute sequelae of SARS-CoV-2 infection across claims and electronic health record databases. medrxiv.org10.1101/2021.03.19.21253756.</Citation></Reference><Reference><Citation>Strahm C, et al. Symptoms compatible with long coronavirus disease (COVID) in healthcare workers with and without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection&#x2014;Results of a prospective multicenter cohort. Clin. Infect. Dis. 2022 doi: 10.1093/cid/ciac054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac054</ArticleId><ArticleId IdType="pmc">PMC9383387</ArticleId><ArticleId IdType="pubmed">35090015</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 2021;12:6571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen KJ, et al. Day-by-day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalized healthcare workers: A 90-day follow-up study. Int. J. Infect. Dis. 2021;108:382&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8133825</ArticleId><ArticleId IdType="pubmed">34022336</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EL, et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme. Eur. Heart J. 2022;43:1124&#x2013;1137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Carazo S, et al. Physical, psychological and cognitive profile of post-COVID condition in healthcare workers, Quebec, Canada. medRxiv. 2022 doi: 10.1101/2022.03.08.22272057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.08.22272057</ArticleId><ArticleId IdType="pmc">PMC9379818</ArticleId><ArticleId IdType="pubmed">35983264</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: A longitudinal cohort study. JAMA Neurol. 2022;79:509&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkan M, et al. Patient-reported outcome measures after hospitalization during the covid-19 pandemic: A survey among covid-19 and non-COVID-19 patients. Int. J. Gen. Med. 2021;14:4829&#x2013;4836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8405220</ArticleId><ArticleId IdType="pubmed">34471377</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Niyatiwatchanchai N, et al. Comparative study of early impacts of post-COVID-19 pneumonia on clinical manifestations, pulmonary function, and chest radiographs. Medicina. 2022;58:216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8877355</ArticleId><ArticleId IdType="pubmed">35208539</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlake JH, et al. Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: A single center, observational study. PLoS ONE. 2021;16:e0255774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8357130</ArticleId><ArticleId IdType="pubmed">34379644</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;raas A, et al. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study. PLoS ONE. 2021;16:e0256142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389372</ArticleId><ArticleId IdType="pubmed">34437579</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;raas A, et al. Self-reported memory problems 8 months after COVID-19 infection. JAMA Netw. Open. 2021;4:e2118717&#x2013;e2118717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8322992</ArticleId><ArticleId IdType="pubmed">34323987</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): A national matched cohort study. Lancet Child Adolesc. Health. 2022;6:230&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021;326:869&#x2013;871. doi: 10.1001/jama.2021.11880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. J. Med. Virol. 2022;94:253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JH, et al. Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. Influenza Respir. Viruses. 2022;16:680&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111447</ArticleId><ArticleId IdType="pubmed">35347854</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of post COVID-19 condition symptoms: a systematic review and meta-analysis of cohort study data, stratified by recruitment setting. European Centre for Disease Prevention and Controlhttps://www.ecdc.europa.eu/en/publications-data/prevalence-post-covid-19-condition-symptoms-systematic-review-and-meta-analysis (2022).</Citation></Reference><Reference><Citation>Augustin M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani, D. &amp; Bosworth, M. Self-reported long COVID after infection with the Omicron variant in the UK - Office for National Statistics. UK Office for National Statisticshttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidafterinfectionwiththeomicronvariant/18july2022 (2022).</Citation></Reference><Reference><Citation>Perlis RH, et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open. 2022;5:e2238804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021 doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023 doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke B, Shwartz T, Pawlik T. MOOSE reporting guidelines for meta-analyse of observational studies. JAMA Surg. 2021;156:787&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">33825847</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol. Rev. 1987;9:1&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">3678409</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin. Trials. 1986;7:177&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2665578</ArticleId><ArticleId IdType="pubmed">9492685</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor. J. Stat. Softw. 2010;36:1&#x2013;48.</Citation></Reference><Reference><Citation>Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. &amp; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med.151, 264&#x2013;9, W64 (2009)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>